Feasibility of interspecies extrapolation in determining the bioequivalence of animal products intended for intramuscular administration

Journal of Veterinary Pharmacology and Therapeutics

Volumn 24, Issue 2, 2001, Pages 125-135

  Martinez, M N ^a   Pedersoli, W M ^a   Ravis, W R ^b   Jackson, J D ^a   Cullison, R ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPI KEL; AMPICILLIN; ANIMAL PRODUCTS NOT CLASSIFIED ELSEWHERE;

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CATTLE; DRUG BIOAVAILABILITY; FEASIBILITY STUDY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SHEEP; SPECIES DIFFERENTIATION; STATISTICS; SWINE;

AMPICILLIN; ANIMAL DISEASES; ANIMALS; AREA UNDER CURVE; CATTLE; CHEMISTRY, PHARMACEUTICAL; FEASIBILITY STUDIES; PENICILLINS; SHEEP; SWINE; THERAPEUTIC EQUIVALENCY;

EID: 0034940890     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2001.00316.x     Document Type: Article

References (34)

1. A theoretical basis for a biopharmaceutic drug classification, the correlation of vitro drug product dissolution and in vivo bioavailability
2. Guidance for Industry: Average Population, and Individual Approaches to Establishing Bioequivalence
3. Bioavailability of Nalidixic acid from uncoated tablets in humans - Part II. Bioavailability in beagles and its correlation with bioavailability in humans and in vitro dissolution rates
4. Basis for selection of the dosage form
5. An intravenous cannulation technique for wine
6. Critical analysis of 'flip-flop' phenomenon in two-compartment pharmacokinetic model
7. Physiological parameters in laboratory animals and humans
8. USDA
9. Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives
10. Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to sheep
11. Effect of the injection site on the pharmacokinetics of procaine penicillin G in horses
12. Review article, comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals
13. Bioavailability of cyclandelate from capsules in beagle dogs and dissolution rate: Correlations with bioavailability in humans
14. The effect of in-vivo dissolution, gastric emptying rate, and intestinal transit time on the peak concentration and area-under-the-curve of drugs with different gastrointestinal permeabilities
15. Human food safety considerations
16. Bioequivalence of ivermectin formulations in pigs and cattle
17. Comparative bioavailabilities from truncated blood level curves
18. The absorption of drugs from subcutaneous and intramuscular injection sites
19. Injection sites and drug bio-availability
20. 0-inf)
21. Bioavailability Bioequivalence Assessments
22. Comparative pharmacokinetics of ampicillin-sulbactam combination in calves and sheep
23. Comparative plasma ampicillin levels and bioavailability of five parenteral ampicillin formulations in ruminant calves
24. Bioavailability of Nalidixic acid from uncoated tablets in humans - Part II. Bioavailability in beagles and its correlation with bioavailability in humans and in vitro dissolution rates
25. Physico-chemical and formulation-induced veterinary drug-product bioinequivalencies
26. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species
27. Comparative pharmacokinetics of doxycycline in cats and dogs
28. Effect of the injection site on the bioavailability of amoxycillin trihydrate in dairy cows
29. Consideration of sheep as a minor species, comparison of drug metabolism and disposition with other domestic ruminants